Bumper Offer - Urjas oil Just @ Rs. 1
Relgin 1 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Parkinson's Disease.
The right dosage of Relgin 1 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Relgin 1 Tablet have been listed ahead. Such side effects of Relgin 1 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Relgin 1 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Relgin 1 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Psychosis, Low Blood Pressure (Hypotension) must refrain from the use of Relgin 1 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Relgin 1 Tablet are listed in the contraindications section below.
Drug interactions for Relgin 1 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Relgin 1 Tablet is not safe while driving, and is is not addictive in nature.
Relgin 1 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Relgin 1 Tablet is used -
Moderate
Mild
Is the use of Relgin 1 Tablet safe for pregnant women?
Relgin may have some side effects during pregnancy. Pregnant women should discontinue the use of Relgin, and talk to their doctor, if they notice any discomfort.
Is the use of Relgin 1 Tablet safe during breastfeeding?
Taking Relgin may lead to serious side effects if you are breastfeeding. Relgin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Relgin 1 Tablet on the Kidneys?
Relgin rarely harms the kidneys.
What is the effect of Relgin 1 Tablet on the Liver?
Very few cases of side effects of Relgin on the liver have been reported.
What is the effect of Relgin 1 Tablet on the Heart?
Relgin is completely safe for the heart.
Relgin 1 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Relgin 1 Tablet unless your doctor advises you to do so -
Is this Relgin 1 Tablet habit forming or addictive?
No, there is no any evidence that Relgin 1 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Relgin 1 Tablet as you may feel sleepy.
Is it safe?
Yes, Relgin 1 Tablet is safe for use.
Is it able to treat mental disorders?
Yes, Relgin 1 Tablet is useful in treating mental disorders.
Interaction between Food and Relgin 1 Tablet
Eating certain foods may increase the time it takes Relgin 1 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Relgin 1 Tablet
Taking alcohol with Relgin 1 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086
